Trimethoprim-d3
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Trimethoprim-d3
Description :
Trimethoprim-d3is the deuterium labeled Trimethoprim. Trimethoprim is a bacteriostatic antibiotic and an orally active dihydrofolate reductase inhibitor. Trimethoprim is active against a wide range of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim has the potential for urinary tract infections, Shigellosis and Pneumocystis pneumonia treatment[1][2][3].UNSPSC :
12352005Hazard Statement :
H302, H361, H373, H401, H411Target :
Antibiotic; Antifolate; BacterialType :
Isotope-Labeled CompoundsRelated Pathways :
Anti-infection; Cell Cycle/DNA DamageField of Research :
InfectionPurity :
99.24Solubility :
10 mM in DMSO|DMSO : 50mg/mL (ultrasonic) |H2O : 0.67mg/mL (ultrasonic)Smiles :
COC(C=C1CC2=CN=C(N)N=C2N)=C(C(OC)=C1)OC([2H])([2H])[2H]Molecular Formula :
C14H15D3N4O3Molecular Weight :
293.34Precautions :
H302, H361, H373, H401, H411References & Citations :
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Laskowska, E., et al., Trimethoprim induces heat shock proteins and protein aggregation in E. coli cells. Curr Microbiol, 2003. 47 (4) : p. 286-9.; Brogden, R.N., et al., Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections. Drugs, 1982. 23 (6) : p. 405-30.; Xiaojian Wang, et al. A Trimethoprim Conjugate of Thiomaltose Has Enhanced Antibacterial Efficacy In Vivo. Bioconjug Chem. 2018 May 16;29 (5) :1729-1735.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development ReportedCAS Number :
[1189923-38-3]

